Adjusting fracture probability by trabecular bone score. Canada, GE-Lunar, Osteoporosis, TBS Osteo - All publications about FRAX, TBS-adjusted FRAX
Spine Trabecular Bone Score Precision, a Comparison Between GE Lunar Standard and High-Resolution Densitometers GE-Lunar, Technical variability, USA
Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS). Alendronate, Bisphosphonate, Calcium, Denosumab, GE-Lunar, Longitudinal, Risedronate, Spain, Teriparatide, Testosterone, Treatment (anti-osteoporotic treatments), Vitamin D
Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposure. France, GE-Lunar, Glucocorticoids, Rheumatoid arthritis, Rheumatology, Secondary osteoporosis, Systemic sclerosis, Treatment (anti-osteoporotic treatments)
TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Austria, GE-Lunar, Microarchitecture, Osteoporosis
Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta Austria, GE-Lunar, HR-pQCT, Osteogenesis imperfecta, Secondary osteoporosis
Vertebral microarchitecture and fragility fracture in men: a TBS study. GE-Lunar, Men, Osteoporosis, USA
Evaluating spine micro-architectural texture (via TBS) discriminates major osteoporotic fractures from controls both as well as and independent of site matched BMD: the Eastern European TBS study. Bulgaria, GE-Lunar, Hologic, Osteoporosis, Romania, Serbia, Ukraine
Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women. GE-Lunar, Osteoporosis, USA
Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer Aromatase inhibitor, Breast cancer, Cancer, Exemestane, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Tamoxifen, Treatment (anti-osteoporotic treatments)